Artificial Intelligence Can Predict Personalized Immunotherapy Outcomes in Cancer

Area of Science:

• Oncology
• Artificial Intelligence
• Immunotherapy
• Precision Medicine

Background:

• Artificial intelligence (AI) is rapidly advancing personalized immunotherapy for cancer.
• Optimizing immunotherapy requires integrating complex data for accurate patient stratification and treatment planning.

Purpose of the Study:

• To review the current progress of AI applications in personalized cancer immunotherapy.
• To identify challenges and future research directions for AI in clinical settings.

Main Methods:

• Integration of multi-omics and imaging data using AI for cancer diagnosis and biomarker discovery.
• Development of AI-driven predictive models for treatment response and adverse reactions.
• Formulation of personalized treatment plans and patient stratification using AI.

Main Results:

• AI models demonstrate accuracy in cancer diagnosis and biomarker identification.
• AI effectively predicts treatment outcomes and adverse events, enabling personalized treatment strategies.
• AI facilitates precise patient stratification and clinical trial matching.

Conclusions:

• AI significantly optimizes personalized immunotherapy by addressing diagnostic and therapeutic challenges.
• Future research should focus on data management, explainable AI, and model generalization for clinical applicability.
• Large-scale studies and prospective trials are crucial for validating AI models in precision medicine.